This is a working overview of prohibited list, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-02-15. Anything still debated is marked as such rather than presented as settled.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
| Property | Value | Notes |
|---|---|---|
| Dosage form | Lyophilized powder in sealed vial | Reconstituted before analytical or laboratory use |
| Reconstitution solvent | Sterile or bacteriostatic water | Bacteriostatic water limits microbial growth in multi-use vials |
| Typical working pH | Near neutral, buffered | Strongly acidic or basic conditions promote degradation |
| Stability indicator | Loss of main HPLC peak over time | Aggregation and oxidation are common degradation routes |
| Documentation | Batch certificate of analysis | Covers identity, purity and sometimes sterility testing |
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
== Other uses == Chart Rulership or Chart Ruler, in astrology Comfort room, another name for a public toilet Consciousness raising, in social activism Continuing resolution, a type of appropriations legislation in the US Councillor, a title for a public servant, used in Australia and New Zealand Cree language (ISO 639 alpha-2 code CR) Critical reading, a skill measured by the Scholastic Aptitude Test (SAT) Crore, a number representing 10,000,000 in the Hindu-Arabic numeral system Cr$ or ₢, symbol for Brazilian cruzeiro
To play the young Vance, Rocky Carroll underwent make-up procedures that he described as "a little instant facelift". In 1991, Vance was a student at the Naval War College in Rhode Island, and began to take an interest in black operations. He even imagines one himself: Operation Frankenstein, which would later play a big part in the season eight finale. NIS (later renamed NCIS) takes an interest in him and he is recruited by Special Agent Whitney Sharp. Vance is trained by Sharp and after a six-week training course, leaves for an operation in Amsterdam, codenamed Trident. He meets his handler, Riley McAllister, who tells him that the target is a Russian agent known to Vance only as "The Russian", later known as Anatoly Zhukov. NIS believes he is bribing sailors for intelligence. Vance meets Eli David, a promising Mossad agent, who tells him he knows of the operation and that the Russian will kill him. Later, Eli betrays Vance to the Russian but it is revealed that this is so he can kill him himself. Eli also tells Vance he has been chosen because he is expendable and would not be missed. Eli and Vance kill the Russian's hit team, but the Russian manages to escape. Eli is unable to find him or who he was. Zhukov would later be killed by Gibbs in another black op in Paris with Jenny Shepard and William Decker. This leads to Decker and Jenny's deaths at the hands of Zhukov's lover Natalya before she is killed by Franks and her body burned with Jenny's mansion to cover up Shepard's mistakes.
=== Neutron source === The oxide of 241Am pressed with beryllium is an efficient neutron source. Here americium acts as the alpha source, and beryllium produces neutrons owing to its large cross-section for the (α,n) nuclear reaction:
Sources: en.wikipedia.org
== Research == Pseudoephedrine has been studied in the treatment of snoring. However, data are inadequate to support this use. A study has found that pseudoephedrine can reduce milk production in breastfeeding women. This might have been due to suppression of prolactin secretion. Pseudoephedrine might be useful for lactation suppression.
Buckley, Michael; Collins, Matthew; Jane Thomas-Oates; Wilson, Julie (2009). "Species identification by analysis of bone collagen using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry". Rapid Communications in Mass Spectrometry. 23 (23): 3843–3854. doi:10.1002/rcm.4316. PMID 19899187. Wikidata Q30877743. Irene Kuiper; Ellen L Lagendijk; Pickford, Russell; Jeremy P Derrick; Gerda E M Lamers; Jane E Thomas-Oates; Ben J J Lugtenberg; Guido V Bloemberg (2004). "Characterization of two Pseudomonas putida lipopeptide biosurfactants, putisolvin I and II, which inhibit biofilm formation and break down existing biofilms". Molecular Microbiology. 51 (1): 97–113. doi:10.1046/j.1365-2958.2003.03751.x. PMID 14651614. Wikidata Q44677338. M Fukuda; E Spooncer; J E Oates; Dell, Anne; J C Klock (1984). "Structure of sialylated fucosyl lactosaminoglycan isolated from human granulocytes". Journal of Biological Chemistry. 259 (17): 10925–10935. doi:10.1016/s0021-9258(18)90602-2. PMID 6432790. Wikidata Q70494199.
CAVE systems included multiple flat screen displays, typically at least three walls to surround the human player, and incorporated some type of tracking sensor system to match the images on the walls to what direction the player was looking. Early applications of CAVE system were game-based demonstrations, but the cost remained prohibitive for commercial deployment even through the 2010s. Around this same time in the 1990s, major innovations in real-time 3D graphics had been made across computer, console, and arcade video games, and with further improvements in affordable consumer technologies, arcade games began to decline as they could not compete with these innovations. Arcade game manufacturers instead focused on offering games that could not easily be replicated at home, which included the introduction of VR-based arcade games. For example, the Virtuality Group produced its Virtuality line of arcade games starting in the early 1990s that typically included a VR headset with head-tracking and other features. However, the cost and upkeep of these machines made it difficult to continue support for them. There remained strong interest from academics to explore what VR, along with augmented reality and other mixed reality systems, could bring to video games, through the 2000s, but these games were mostly prepared for research proof-of-concepts to demonstrate the interaction of VR hardware, software, and human motion rather than for commercial release, since hardware costs were still high.
Sources: en.wikipedia.org
=== AlphaCor === In cases where there have been several graft failures or the risk for keratoplasty is high, synthetic corneas can substitute successfully for donor corneas. Such a device contains a peripheral skirt and a transparent central region. These two parts are connected on a molecular level by an interpenetrating polymer network, made from poly-2-hydroxyethyl methacrylate (pHEMA). AlphaCor is a U.S. FDA-approved type of synthetic cornea measuring 7.0 mm in diameter and 0.5 mm in thickness. The main advantages of synthetic corneas are that they are biocompatible, and the network between the parts and the device prevents complications that could arise at their interface. The probability of retention in one large study was estimated at 62% at 2 years follow-up.
== Environmental behavior == 2-Pyridone is rapidly degraded by microorganisms in the soil environment, with a half life less than one week. Organisms capable of growth on 2-pyridone as a sole source of carbon, nitrogen, and energy have been isolated by a number of researchers. The most extensively studied 2-pyridone degrader is the gram-positive bacterium Arthrobacter crystallopoietes, a member of the phylum actinomycetota. Numerous actinomycetotes have been shown to degrade pyridine or alkyl-, carboxyl-, or hydroxyl-substituted derivatives. 2-Pyridone degradation is commonly initiated by mono-oxygenase attack, resulting in a diol, such as 2,5-dihydroxypyridine, which is metabolized via the maleamate pathway. Fission of the ring proceeds via action of 2,5-dihydroxypyridine monooxygenase, which is also involved in metabolism of nicotinic acid via the maleamate pathway. In the case of Arthrobacter crystallopoietes, at least part of the degradative pathway is plasmid-borne.
==== Transistors ==== Bismuth-based materials have been claimed to enable smaller, faster, and more energy-efficient transistors than traditional silicon. Bismuth offers a small bandgap and high electron mobility. It has topological insulator states, conducting along its surface/edges while still insulating internally. Two-dimensional semiconductor (2D) materials can be produced from it, enabling thinner and higher-performance devices. Such 2D bismuth materials support subnanometer channel lengths, surpassing silicon's practical limits. However, bismuth's anisotropic heat transport can complicate chip design. Bismuth telluride (Bi2Te3) has been investigated for use in thermoelectric transistors that use temperature gradients (e.g., via laser illumination) to generate electricity, yielding 0.7093 μW in experimental setups. They operate by leveraging the Seebeck effect, using a temperature difference to drive charge carrier movement. Bismuth oxyselenides (Bi2O2Se and Bi2SeO5) have been investigated for use in field-effect transistors (FETs). These 2D materials exhibit high electron mobility (e.g., 10–15 cm2/(V·s)) and stability in air. One study reported that these materials enabled transistors that were 40% faster and 10% more efficient than Intel's 3 nm chips. Bismuth can reduce contact resistance when paired with 2D semiconductors such as MoS2. This eliminates the Schottky barrier—a common efficiency issue in metal-semiconductor interfaces.
Sources: en.wikipedia.org
Desiccated storage at −20 °C is conventional, with −80 °C for extended periods. Vials should be warmed to room temperature before opening to prevent condensation on the powder.
It usually reports batch-specific results for purity by chromatography, identity by mass spectrometry, and sometimes peptide content and residual solvents. It applies only to the batch tested, not to a supplier's wider stock.
Purity describes the proportion of the chromatographic signal from the target compound, while peptide content measures how much of the vial's physical mass is peptide. Counter-ions, water and residual acid make up the remainder, so content values are commonly lower.
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.